This multi-module curriculum is designed for all health-care providers and covers various topics.
Excerpt:
CDC has released a 2017 update to the clinical practice guidelines for PrEP. The new guidelines
Northeast/Caribbean (NECA) AETC offers online continuing education accredited videos and monographs. Here you can watch NECA AETC lectures, complete self-study modules, and earn continuing education c...
In response to newly identified, community-based HIV epidemics, the AETC NCRC has pulled together the following AETC Program and U.S. Centers for Disease Control and Prevention resources for public he...
Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment. The AETC National Coordinating Resource Center and its partner,...
This PrEP protocol is adapted from the US Public Health Service, Preexposure Prophylaxis for the Prevention of HIV Infection in the United States: 2017 Update, A Clinical Practice Guideline. Use this...
The purpose of this training is to improve providers’ capacity to provide routine testing and HIV treatment and prevention, and to give a foundation-building overview of clinical best practices in pre...
Slide set provides an overview of HIV and STI testing in the primary care setting; reviews current recommendations for STI screening in the general population, and in higher-risk individuals; reviews...
This slide set includes an overview of cabotegravir, and provides updates from the phase III PrEP trial and next steps for long-acting PrEP.
This PrEP Action Kit includes clinical resources which consist of:
Slides from a 2-day training program for primary health and social service providers, which combines recent research with practical guidelines for a comprehensive approach to the care of persons with...
The National HIV Curriculum (NHC) provides free, up-to-date content for clinicians to learn about HIV diagnosis, treatment, and prevention. The 37 lessons and corresponding question bank topics offer...
Training slides from a presentation discussing ways pre-exposure prophylaxis (PrEP) may be delivered in the future, how broadly neutralizing antibodies work to prevent HIV infections, and the antiretr...
This slide presentation provides an overview of one county's PrEP pilot project (now known as the PrEP Initiative) and its 2-year evaluation to determine the public health/clinical effectiveness and i...
This presentation is designed for oral health providers. It covers the following:
This resource provides information related to HIV testing and prevention for adolescents. Adolescents are a special population to be considered for HIV testing and prevention, as many adolescents are...
(Recorded September 23, 2020) Session I from NEAETC's More Than Health Care series on improving quality of life for people with HIV, HCV, and substance use disorders.
Emely Orellana de Bauti...
Recorded December 9, 2020. This training discusses what is known about sexual behavior during the COVID-19 pandemic and what constitutes safer sex in the COVID-19 era.
The talk contextualiz...
The Pacific AETC’s HIV Learning Network (HIVLN) is a free, longitudinal tele-health HIV training and consultation program for HIV clinical care teams and individual clinicians in the Pacific Region. H...
This series provides best practices and updates for HIV, viral hepatitis, mental health and STI treatment in the correctional setting.
(R...
Recorded January 6, 2021.
This training covers the essentials of pre- and non-occupational post-exposure prophylaxis for providers.
Rebecca Thal, NP-C, AAHIVS...
Honoring National Native HIV/AIDS Awareness Day, these training slides review how to start a PrEP program in clinical settings that serve the native community. Topics include identifying the differenc...
Initiation and continuation of PrEP has shifted over the years from specialty care to primary care due to higher patient access, improved rapport through longitudinal and comprehensive care, and simpl...
Training slides provide a review of recommended laboratory testing for patients on PrEP, barriers to PrEP engagement during the pandemic, advantages/disadvantages of PrEP telemedicine, and characteris...
New England AETC's HIV Resource Library is a compilation of curated resources and education packets on HIV, viral hepatitis, and related public health topics.
Each Library topic page is an organized li...
Recorded on 6/14/2021
This presentation discussed a status neutral approach in addressing sexual health in adolescents and includes information regarding preventing and addressing STIs and HIV...
Recorded June 15, 2021.
Training materials review the impact of HIV among Black men who have sex with men (BMSM), discuss perceived ideas about Black MSM and PrEP uptake, and identify strategies for re...
This publication discusses the advantages and challenges of telePrEP, the use of telemedicine specifically for pre-exposure prophylaxis (PrEP), and provides best practices for clinicians and PrEP prog...
These presentation slides were from an annual event presented by the Pacific AETC's Arizona regional partner, California Prevention Training Center, and Curry International TB Center for Arizona-based...
Three training slide sets from the "HIV in the Era of COVID-19" telemedicine webinar series designed to share best practices on HIV prevention & care, and pre-and-post-exposure prophylaxis (PrEP a...
Comprehensive package of recommendations and practical tools for clinicians to support provision of pre-exposure prophylaxis (PrEP), especially in New York State.
Topics covered include:
Dr. Adrienne E Shapiro discusses highlights from the 2021 IAS Conference.
Developed by the Northeast/Caribbean AETC's Puerto Rico Regional Partner, this 1-page infographic is designed for providers to help increase patient awareness and understanding of PrEP. A Spanish vers...
A downloadable/printable pocket guide for screening and prescribing pre-exposure prophylaxis (PrEP). It includes information about PrEP indications, contraindications/cautions, required testing, presc...
After this learning session, attendees will be able to discuss:
Training slides describe the safety and efficacy of the Dapivirine vaginal ring for sustained delivery of ARV drugs.
Training slides review the latest updates for the use of PrEP for HIV prevention in the U.S.
(Available from 1/1/2022 to 6/30/2022)
This 18-question quiz covers important aspects of pre-exposure prophylaxis (PrEP) to prevent HIV.
QuizTime delivers one multiple choice question each weekday to...
Pre-Exposure Prophylaxis (PrEP) is recommended as an HIV prevention option for anyone with risks of acquiring HIV infection through sex or drug use.
PrEP IndicationsDiscuss PrEP...
Training slides provide a summary of HIV prevention updates presented at CROI 2022, including new data on CAB-LA PrEP and other prevention modalities like islatravir, and dapivirine vagina...
After this learning session, attendees will be able to:
Training slides review the background and importance of PrEP in the Southeast and identify provider and patient barriers to PrEP, PrEP eligibility, prescribing, counseling, adverse effects and lab mon...
Training slides provide a review of RCT and real-world data and explain why people choose the 2-1-1 prescribing schedule.
Training slides review changes to the CDC PrEP Guidelines, updated in December 2021.
CEUs are no longer available.
Training slides review the following:
(Recorded 3/4/22)
Training program on new long-acting HIV injectable Cabotegravir for PrEP and Cabotegravir/Rilpivirine for treatment. Dr. Amy Colson addresses efficacy, benefits and challenges of long...
This video describes the goal of pre-exposure prophylaxis (PrEP), along with specific types of PrEP, how to prescribe PrEP, and how to manage patients on PrEP...
Training slides review new guidelines for PrEP, and the role of HIV RNA and Antigen/Antibody testing in evaluating HIV while on PrEP.
Training slides provide an update on the epidemiology of HIV in the U.S., antiretrovirals, PrEP, the HIV “cure” case, COVID-19 prevention & treatment, and more from CROI 2022.
Training slides review challenges (lack of awareness and interest, and risk perception), and opportunities (improve uptake, sustainability, and adherence) for PrEP for people with injection drug use d...
(Recorded 4/20/22)
In this webinar, Dr. Kevin Ard provided updated guidance related to PrEP, informed by new PrEP guidelines and the FDA approval of injectable PrEP.
This session has 1.0 credit availabl...
The 69 slides on Occupational Exposure to HIV, HCV, and HBV provide an overview of basic HIV information as well as fulfill the following objectives:
This guideline is a comprehensive compilation of federal recommendations about biomedical, behavioral, and structural interventions that can help reduce the risk of HIV transmission from persons with...
This Policy Brief is a follow-up document to the 2011 WHO document, "Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people"...
36 evidence-based recommendations are provided for interventions to optimize the HIV care environment; increase HIV testing and linkage to care, treatment coverage, retention in care, and viral suppre...
The paper, developed in collaboration with Health Management Associates (HMA), highlights examples of innovative Medicaid partnerships and financing arrangements for HIV prevention services from four...
There was a pharmacokinetic study presented at the Conference on Retroviruses and Opportunistic Infections in Boston in February. It evaluated concentrations of tenofovir (TFV) and TFV-diphosphate (DP) in genital and rectal tissue. Also in anogenital fluid samples after administration of oral tenofo...
Tenofovir disoproxil fumarate (TDF) may cause decreases in bone mineral density (BMD). In both HIV-infected patients treated with TDF-containing ARV regimens, and in HIV-uninfected persons who use it for PrEP. A substudy of the large iPrEx trial of TDF/FTC PrEP in MSM and transgender women evaluated...
At the ASM Microbe meeting in June, researchers from Gilead Sciences presented data on use of TDF/FTC (Truvada) PrEP in the United States according to sex and race. They evaluated national pharmacy databases to identify prescriptions of TDF/FTC given for PrEP between January 2012 and September 2015;...
PARTNER1, whose results were reported last year,(1) was one of the studies that supported current efforts to promote the growing scientific consensus supporting "Treatment as Prevention" (TasP) or Undetectable = Untransmittable (U=U).
PARTNER1 evaluated HIV transmission risk in a European multicenter...
A long-acting formulation of the investigational integrase inhibitor cabotegravir (CAB) is being studied as a single agent for HIV prevention. (CAB also has been studied, in combination with long-acting rilpivirine, as treatment for people with HIV, see Long-Acting Injectable ART: Cabotegravir + Ril...
The FDA recently approved the use of an extended-release injectable formulation of the integrase inhibitor cabotegravir (CAB) for preexposure prophylaxis (PrEP) for adults and adolescents at risk for HIV infection. After two initial intramuscular (IM) injections given 1 month apart, it is administer...
In December 2021, the U.S. Centers for Disease Control and Prevention issued thoroughly revised and updated PrEP guidelines. The guidelines include important new information on the use of oral PrEP (TDF/FTC and TAF/FTC) and recommendations on the use of injectable cabotegravir (CAB) as PrEP.
Key upda...
We recognize the work of our AETC colleagues who dedicate additional time and resources to research beyond the scope of the AETC Program. The following is a compilation of HIV-related peer-reviewed studies produced by AETC-affiliated researchers and faculty, published in 2021.
If you're aware of othe...
Pharmacists have been identified by the CDC as key professionals in achieving one of the CDC’s goals of Ending the HIV Epidemic in the U.S. by preventing HIV infection. Below are some of the most common questions received at the AETC National Clinician Consultation Center (NCCC) from pharmacists abo...
...
...